Harvard gets $1.2M to develop oral antibiotics that kill drug-resistant infections
Harvard researchers receive $1.2 million from CARB-X to develop enhanced oral antibiotics for drug-resistant bacteria listed by CDC.
Source: beckershospitalreview.com